Corresponding author: by Jin Hee Lee et al.
 
Total β-adrenoceptor deficiency results  
in cardiac hypotrophy and negative inotropy 
Samuel Lee
1, Sabrina Grafweg
1, Toni Schneider
2, Maria Jimenez
3, 
Jean-Paul Giacobino
3, Alexander Ghanem
4, Klaus Tiemann
5, Wilhelm Bloch
6, 
Jochen Müller-Ehmsen
1, Robert H.G. Schwinger
7, Klara Brixius
1,6 
1  Laboratory of Muscle Research and Molecular Cardiology, Department III of Internal Medicine, 
University of Cologne, Cologne, Germany 
2  Institute of Neurophysiology, University of Cologne, Cologne, Germany 
3  Département de Biochimie Médicale, Centre Médicale Universitaire, Université de Genève, 
Geneva, Switzerland 
4  Department of Medicine/Cardiology, University of Bonn, Bonn, Germany 
5  Clinic C for Internal Medicine, Department of Cardiology and Angiology, University of Muenster, 
Muenster, Germany 
6  Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and 
Sport Medicine, German Sport University Cologne, Cologne, Germany 
7  Medical Clinic II, Weiden, Germany 
CORRESPONDING AUTHOR: 
Priv.-Doz. Dr. rer. nat. Klara Brixius 
Department of Molecular and Cellular Sport Medicine 
Institute of Cardiovascular Research 
German Sport University Cologne 
Carl-Diem-Weg 6 
50933 Cologne, Germany 
Tel.: +49-221-49825220 
Fax: +49-221-49828370 
E-mail: brixius@dshs-koeln.de 
SHORT TITLE: Total β-adrenoceptor deficiency 
  1 
SUMMARY 
The present study investigated cardiac function in hearts of mice with total deficiency 
of the β1-, β2- and β3-adrenoceptors (TKO) in comparison to wildtype mice (WT). We 
investigated cardiac morphology and echocardiographic function, measured protein 
expression of Ca
2+-regulatory proteins, SERCA 2a activity, myofibrillar function, and 
performed running wheel tests. Heart weight and heart-to-body weight ratio were 
significantly smaller in TKO as compared to WT. This was accompanied by a 
decrease in the size of the cardiomyocytes in TKO. Heart rate and ejection fraction 
were significantly diminished in TKO as compared to WT. Protein expression of 
SERCA 2a, the ryanodine receptor and the Na
+/Ca
2+-exchanger were similar in TKO 
and WT mice, but phospholamban protein expression was increased. PKA-
dependent phosphorylation of phospholamban at serine 16 was absent and CaMKII-
dependent phosphorylation at threonine 17 was decreased in TKO. All alterations 
were paralleled by a decrease in SERCA 2a-activity. A similar maximal calcium-
dependent tension but an increased myofibrillar calcium-sensitivity was measured in 
TKO as compared to WT. We did not observe relevant functional impairments of 
TKO in running wheel tests. In the absence of β-agonistic stimulation, SERCA 2a 
activity is mainly regulated by alterations of phospholamban expression and 
phosphorylation. The decreased SERCA 2a activity following β-adrenoceptor 
deficiency may be partly compensated by an increased myofibrillar calcium-
sensitivity. 
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INTRODUCTION 
β-adrenergic stimulation is one of the main neurohumoral mechanisms modulating 
cardiac function in physiological (e.g. exercise) as well as pathophysiological 
conditions (e.g. heart failure). Three β-adrenoceptor (β-AR) subtypes have been 
described with the β1- and β2-adrenoceptors mediating positive inotropic reactions 
mainly by stimulating the Gs-protein/adenylate cyclase/protein kinase A pathway [for 
review see (Wallukat 2002)], whereas β3-adrenergic stimulation is coupled to a 
cardiac release of nitric oxide via activation of the endothelial NO-synthase (Brixius et 
al. 2004, Gauthier et al. 1998, Gauthier et al. 1996, Moniotte et al. 2001), the 
functional implication of which has still to be clarified. 
 
β-adrenergic positive inotropic effects are paralleled by an increase of intracellular 
systolic Ca
2+-concentrations due to an increase in the Ca
2+-influx through the L-type 
Ca
2+-channels (Bers 2002), which is subsequently followed by an increase in the 
Ca
2+-release out of the sarcoplasmic reticulum, as well as a decrease in the 
myofibrillar Ca
2+-sensitivity (Brixius et al. 2002, van der Velden et al. 2003) and an 
increase in the Ca
2+-accumulation by the sarcoplasmic reticulum (Bers 2002). The 
latter can be attributed to an increase in the activity of the sarcoplasmic reticulum 
Ca
2+-ATPase (SERCA 2a) due to an increased phosphorylation of serine 16 (PLB-
Ser16) and threonine 17 (PLB-Thr17) phospholamban (PLB) (Kranias and Solaro 
1982, MacLennan and Kranias 2003). 
 
Only recently, a transgenic mouse model was described with chronic deficiency of all 
three β-adrenoceptor subtypes (Bachman et al. 2002, Bachman et al. 2004, Jimenez 
et al. 2002, Lee et al. 2008). The mice are viable and are characterized by cold 
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intolerance due to impaired adaptive responses of the brown adipose tissue to cold 
exposure. We were now interested in the regulation of the intracellular Ca
2+-
homeostasis and myofibrillar function under conditions of chronic β-adrenergic 
deficiency. Therefore, we investigated cardiac morphology and echocardiographic 
function in total β-adrenoceptor knockout mice in comparison to their isogenic 
littermates. In addition, we measured protein expression of Ca
2+-regulatory proteins, 
SERCA 2a activity, myofibrillar function, and performed running wheel tests. 
 
MATERIALS AND METHODS 
Transgenic animals 
Studies were performed on 12-week-old female β1/2/3-AR-KO mice (TKO = β1/2/3-KO = 
β1
–/–β2
–/–β3
–/–) compared to the respective wildtype mice (WT = β1
+/+β2
+/+β3
+/+). 
Creation of the TKO-mice has been described before (Jimenez et al. 2002). Mice 
were maintained at an artificial light/dark cycle at 20-22 °C with free access to water 
and standard laboratory chow diet. Following cervical dislocation the hearts were 
immediately taken out for further experiments and prepared as described below. The 
investigation conforms with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1985). The experiments were approved by the local animal ethics committee. 
 
Morphological analysis 
After being weighed hearts were fixed with 4% paraformaldehyde, dehydrated with 
alcohol, embedded in paraffin, and cut into 7 µm slices, which were stained with 
hematoxylin/eosin. For each group 4 slices of the left anterior wall were obtained and 
5 photographs were taken at 400fold magnification (Leica DC500) respectively. 
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Cross-sectional areas of 5 cardiomyocytes were determined by digitizing the images 
and computerized pixel counting including only nucleated myocytes for the analysis 
as described by Engelhardt et al. (Engelhardt et al. 1999). 
 
Echocardiography 
Transthoracical echocardiography was performed in 3-month-old mice as previously 
described (Tiemann et al. 2003). Mice were anesthetized with enflurane (3% for 
induction and 0.8–1% for echocardiography) in 50% nitrous oxide and 50% oxygen 
by face mask. The degree of anesthesia was adapted to minimize cardiodepressive 
effects. Thus the heart rate during anesthesia was maintained in the physiological 
range of conscious mice under resting conditions. The core temperature was 
maintained at 37°C using a feedback-controlled heating pad. Echocardiography was 
performed using a commercially available ultrasound system equipped with a linear 
array transducer operating at an emission frequency of 15 MHz (harmonic-mode) 
with frame rates up to 280 Hz (HDI-5000, Philips Medical Systems, Bothell, WA, 
USA). Analysis included heart rate, left ventricular end-systolic and end-diastolic 
volume. For calculation of volumes the area length method was used (Ghanem et al. 
2006, Tiemann et al. 2003). 
 
Tissue preparation 
For the preparation of Western blot samples tissue of each heart was prepared as 
previously described (Munch et al. 1998). Briefly, 25-35 mg of left ventricular 
myocardial samples were thawed on ice in threefold volume of chilled preparation 
buffer (in mmol/l: sucrose 300, phenyl methyl sulfonyl fluoride 1, piperazine-N,N-
bis(2-ethane sulfonic acid) 20, EDTA 1, Pi 10, pH 7.4). Care was taken to dissect 
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myocardial tissue from connecting tissue, vessels, and pericardium. Samples were 
homogenized with a glass-teflon homogenizer (Potter Typ RN 24, 350 upm, IKA 
Labortechnik Stauffen) under constant 4 °C temperature. The homogenates were 
immediately shock-frozen in liquid nitrogen and stored at – 80 °C in freezing buffer (in 
mmol/l: sucrose 400, NaH2PO4 50, EDTA 10, piperazine-N,N-bis(2-ethane sulfonic 
acid) 5, 2-amino-2-(hydroxymethyle)-1.3.propandiol 5, pH 7.2). Protein content was 
measured according to Bradford (Bradford 1976). 
 
Western blot analysis 
For detection of SERCA 2a, PLB, phosphorylated PLB-Ser16, phosphorylated PLB-
Thr17, ryanodine receptor and Na
+/Ca
2+-exchanger (NCX) in WT and TKO 
myocardium, immunoblotting techniques were performed as described previously, 
with slight modifications (Schwinger et al. 1995). Equal amounts of membrane 
proteins (10 μg) were separated by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) with 4% stacking gel and 12% acrylamide. The linear 
range of the antibodies used was determined in previous experiments (Schwinger et 
al. 1995). To control protein load, we performed Coomassie blue stainings of the gel. 
After blotting, we controlled protein transfer using Ponceau red staining of the 
membrane. For the immunoreaction, the following commercially available primary 
antibodies were used: anti-SERCA 2a (mouse) from Affinity BioReagents (Golden, 
CO, USA); anti-ryanodine receptor (mouse) from Affinity BioReagents; anti-PLB 
phosphorylated at Ser16 and Thr17 (rabbit), antibodies against sequence 
RSAIRRASTIEY (residues 9-19 of PLB, +Y) in which Ser16 or Thr17 is 
phosphorylated, from Cyclacel (Dundee, UK); anti-PLB (mouse) from Upstate 
Biotechnology (Dundee, UK), clone A1, anti-Na(+)/Ca(2+) exchanger (mouse) from 
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Novus Biologicals (Littleton, CO, USA). For detection, after washing procedures with 
TBST and TBS, a secondary peroxidase-conjugated mouse or rabbit IgG (Sigma) 
was used where appropriate. To detect antibody binding, an enhanced 
chemoluminescence assay (Lumi-Light Western Blotting Substrate, Roche, 
Grenzach, Germany) was used. After exposure to film (Hyperfilm ECL, Amersham 
Biosciences, Buckinghamshire, UK) and scanning, the bands were quantified by 
densitometry. 
 
Preparation of the SR 
The SR was prepared according to the methods described by Meissner and 
Henderson (Meissner and Henderson 1987) and Sitsapesan and Williams 
(Sitsapesan and Williams 1990). Myocardial tissue was ground in liquid nitrogen. The 
following preparation was made at 4 °C in the cold room. The tissue was chilled in 
ice-cold homogenisation buffer (in mmol/l: sucrose 300, PMSF 1, PIPES 20, EDTA 
10 and NaH2PO4 50, pH 7.4), containing NaH2PO4 to inhibit phosphatases, thereby 
avoiding in vitro PLB dephosphorylation. PMSF irreversibly inhibits serine proteases 
by sulfonylation of the serine residue in the active site of the protease and thereby 
avoids protein decomposition. Connective tissue was carefully trimmed away, and 
myocardial tissue was homogenized with a motor-driven homogenizer (Braun, 
Melsungen, Germany). The preparations were stored at − 80 °C in a buffer 
containing (in mmol/l) sucrose 400, HEPES 5, Tris 5, EDTA 10 and NaH2PO4 50, pH 
7.2. 
 
Measurement of SERCA 2a activity 
Analysis of SERCA 2a activity was carried out according to the method described by 
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Chu et al. (Chu et al. 1988), which is based on coupled enzymatic reactions as 
follows: 1. ATP → ADP + Pi (this reaction is catalysed by SERCA 2a), 2. ADP + 
phosphoenolpyruvate → ATP + pyruvate (catalysed by pyruvate kinase), 3. pyruvate 
+ NADH → lactate + NAD
+ (catalysed by lactate dehydrogenase). The oxidation of 
NADH was continuously monitored by the decrease in absorbance at 340 nm with a 
spectrophotometer (Beckman DU 640). The reaction was carried out in 1 ml at 37 °C. 
20 µl of the SR preparation (final protein concentration, 50 μg/ml) was suspended in 
1000 μl of the reaction mixture. The reaction mixture had the following composition 
(in mmol/l: MOPS 21, NaN3 4.9, EGTA 0.06, KCl 100, MgCl2 3, phosphoenolpyruvate 
1, NADH 0.2 and pyruvate-lactate dehydrogenase LDH enzyme mixture (8.4/12 U)). 
This led to the following concentrations in the cuvette (in mmol/l): MOPS 21, NaN3 
4.9, EGTA 0.06, KCl 100, MgCl2 3, phosphoenolpyruvate 1, NADH 0.2, sucrose 7, 
HEPES 0.05, Tris 0.05, EDTA 0.2, PMSF 0.01, PIPES 0.2 and NaH2PO4 1, pH 7.2. 
CaCl2 was added to the reaction mixture to yield the desired free Ca
2+ concentrations, 
calculated according to the method of Fabiato and Fabiato (Fabiato and Fabiato 
1979). Calculations performed by this method are an approximation. We did not 
measure Ca
2+ concentrations directly. The reaction was started with ATP (1 mmol/l) 
and was constant over at least 5 min. The basal activity was measured in the 
absence of Ca
2+ and in the presence of EGTA (4 mmol/l) simultaneously. All 
experiments were carried out in duplicate. Experiments were performed as described 
before (Schwinger et al. 1995). 
 
Triton X skinned fibres measurements 
Left ventricular muscle fibres were prepared as previously described (Brixius and 
Schwinger 2000). Briefly, the fibre bundles (diameter < 0.2 mm) were dissected from 
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the left ventricular papillary muscles and permeabilised at 4 °C for 20 h in a solution 
containing 50% (v/v) glycerol, 1% Triton X, and (in mmol/l) NaN3 10, ATP 5, MgCl2 5, 
EGTA 4, 1,4-dithioerythritol (DTE) 2, and imidazole 20 (pH 7.0). Afterwards, the 
fibres were stored in a similar solution but without Triton X at − 20 °C. For the 
experiments, the Triton X skinned fibre bundles were prepared under the microscope 
and then mounted isometrically and connected to a force transducer in a perfusion 
cuvette (Scientific Instruments, Heidelberg, Germany) in relaxation solution 
(composition in mmol/l: imidazole 20, Na2ATP 10, NaN3 5, EGTA 5, MgCl2 12.5, 
dithiothreitol 1, creatine phosphate 10, creatine kinase 1 mg/ml, free Ca
2+: 10 nM, pH 
7.0). Fibre length was adjusted so that resting tension was just threshold (slack 
position). The fibres were then incubated in contraction solution (composition as 
above, but with increasing concentrations of free Ca
2+ estimated according to the 
method of Fabiato and Fabiato (Fabiato and Fabiato 1979)). The experiments were 
performed at room temperature. To normalize force, the absolute force values 
obtained were divided by the cross-sectional area of the skinned fibres (CSA = 2πr2). 
Experiments were performed as described previously (Brixius and Schwinger 2000). 
 
Measurement of force development 
Force development was measured as described before (Brixius and Schwinger 2000, 
Guth and Wojciechowski 1986) (experimental setup, Scientific Instruments, 
Heidelberg, Germany). The relaxation solution contained (in mmol/l) imidazole 20, 
Na2ATP 10, NaN3 5, EGTA 5, MgCl2 12.5, phospho(enol)-pyruvate 5, NADH 0.6, 
P1,P5-di(adenosine 5’) pentaphosphate 0.2 (myokinase inhibitor), and cyclopiazonic 
acid 25, together with pyruvate kinase 100 U/ml and lactate dehydrogenase 125 U/ml. 
The contraction solution contained calcium EGTA 5 mmol/l instead of EGTA. Both 
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solutions were mixed by a gradient mixer so that Ca
2+ was successively increased 
every 30 s. Free Ca
2+ concentration was determined by calculator programs 
designed for experiments in skinned muscle cells (Fabiato and Fabiato 1979). 
Measurement of developed tension started 3 s after the solution was exchanged. 
Developed tension had reached a stable plateau at that time. 
 
Running wheel tests 
Running wheel tests have been shown to be suitable to assess cardiovascular 
function of transgene mouse models of human cardiovascular diseases (Bernstein 
2003). Mice were held in cages for 4 days in quiet surroundings at room temperature 
of 20-22 °C having the possiblity to exercise on running wheels with free access to 
water and standard laboratory chow diet. The results were measured by a 
tachometer attached to the running wheel. 
 
Materials 
All chemicals were of analytical grade or the best grade commercially available. All 
compounds were dissolved in twice-distilled water and did not change the pH of the 
medium. 
 
Statistical analysis 
Data are presented as mean ± standard deviation. Data analysis was performed 
using Student’s t test for paired and unpaired data, where appropriate. Significance 
was considered at a p-value < 0.05. 
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RESULTS 
Morphometric analysis and echocardiography 
Body weight was similar in TKO- and WT-mice, whereas heart weight and heart-to-
body-weight ratio were significantly decreased in TKO. In line with these findings, 
myocyte cross-sectional area was also significantly decreased. Echocardiographic 
analysis provided evidence that heart rate and ejection fraction were significantly 
diminished in TKO as compared to WT. Thus, chronic β-AR deficiency is 
accompanied by cardiac hypotrophy as well as negative inotropy and chronotropy 
(tab. 1). 
 
Ca
2+-regulatory proteins 
To investigate whether the negative inotropy may be due to alterations of the Ca
2+-
regulatory proteins, we performed Western blot experiments comparing TKO (n = 5) 
and WT (n = 4). The expression of the ryanodine receptor, the Na
+/Ca
2+-exchanger 
and of SERCA 2a were unchanged in the TKO compared to WT. The expression of 
phospholamban was significantly increased, whereas phosphorylation of 
phospholamban at serine 16 and threonine 17 revealed a marked decrease (fig. 1). 
In line with these findings, maximal SERCA 2a activity was significantly decreased in 
TKO compared to the WT (fig. 2). 
 
Myofibrillar function 
To assess myofibrillar function, we measured Ca
2+ sensitivity of skinned fibres in 
TKO and WT mice by performing measurements of force development of Triton X 
skinned fibres within increasing Ca
2+ concentrations (fig. 3). A similar maximal 
calcium-dependent tension (WT 22.6 ± 7.7 mN/mm², n = 6; TKO 26.9 ± 13.4 
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mN/mm², n = 6; n.s.), but an increased myofibrillar calcium-sensitivity was measured 
in TKO as compared to WT (EC50: WT 1.49, 95% confidence interval 1.36-1.62 µM, n 
= 6; TKO 0.97, 95% confidence interval 0.83-1.11 µM, n = 6). 
 
Running wheel tests 
To investigate the influence of the cardiac alterations observed in TKO mice on the 
exercise capacity, TKO and WT mice performed a voluntary running wheel 
experiment. Mean velocity (WT 0.34 ± 0.33 km/h, n = 6; TKO 0.81 ± 0.44, n = 6), trip 
distance (WT 0.33 ± 0.60 km/d, n = 6; TKO 1.19 ± 0.72 km/d, n = 6) and trip time 
(WT 29.0 ± 37.7 min/d, n = 6; TKO 86.6 ± 46.5 min/d, n = 6) were significantly 
increased in TKO as compared to WT (fig. 4). 
 
DISCUSSION 
The present study investigated the influence of β-adrenoceptor deficiency on cardiac 
function using a knockout model. It was shown that the β1/2/3-KO leads to a 
significantly decreased heart weight, heart rate and ejection fraction accompanied by 
altered expression and activity of important Ca
2+-regulating proteins. Chronic β1/2/3-
AR deficiency reduced SERCA 2a activity by an increase in the expression level of 
PLB and a diminished PLB-Ser16 and PLB-Thr17 phosphorylation. In spite of these 
findings, we did not observe relevant functional impairments in running wheel tests 
but rather an increased willingness to run. The decreased SERCA 2a activity 
following  β-adrenoceptor deficiency may be, at least partly, compensated by an 
increased myofibrillar calcium-sensitivity. 
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The regulation of cardiomyocyte growth under physiological and pathophysiological 
conditions is very complex, but one of its controlling signalling pathways is the β-
adrenergic system (MacLellan and Schneider 2000). In β1-overexpression (OE)-mice, 
an increased heart-to-body weight ratio was described which found its expression in 
a substantial hypertrophy of cardiomyocytes and a concomitant fibrosis (Engelhardt 
et al. 1999). While in early studies β2-OE-animals did not seem to have any 
morphological differences compared to their WT, it was shown in later studies that 
overexpression of the β2-adrenoceptor was linked with cardiac hypertrophy 
associated with a cumulative mortality of 81% within 15 months compared to 4% in 
WT-mice (Du et al. 2000). β3-OE-mice featured a decreased heart-to-body weight 
ratio compared to their WT (Kohout et al. 2001). Whereas overexpression of the 
various β-adrenoceptor subtypes alters cardiac morphology, neither the β1- nor the 
β3-KO-mice had an altered heart-to-body weight ratio (Rohrer et al. 1996, Varghese 
et al. 2000). Recently it could be shown, however, that a β1/2-knockout leads to a 
decreased heart-to-body weight ratio (Kiriazis et al. 2008). Since the present study 
also found a decrease in the heart-to-body weight ratio in TKO-mice, whereas the β1- 
and  β3-knockouts did not effect the heart-to-body weight ratio at all, it may be 
concluded that in maintaining a certain myocyte volume there has to be a functional 
redundancy among the β-adrenoceptors, so that only a blockade of at least the β1- 
and the β2-adrenoceptor entails significant changes in the heart-to-body-weight ratio. 
 
Human heart failure is characterized by profound dysregulation of intracellular Ca
2+-
homeostasis. Thus, structural and functional alterations in the Ca
2+ regulatory 
proteins present in the sarcoplasmic reticulum (SR) have been shown to be strongly 
involved in the pathogenesis of heart failure (Yano et al. 2005). Although it is a matter 
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of an ongoing discussion whether SERCA 2a and PLB expression is altered, it can 
be stated that SERCA 2a activity is depressed in the setting of human heart failure 
due to an attenuated PLB-Ser16- and PLB-Thr17 phosphorylation (Dash et al. 2001, 
Schwinger et al. 1995). PLB phosphorylation causes a disinhibition of SERCA 2a 
resulting in an enhanced diastolic Ca
2+ sequestration into the SR (Frank et al. 2003). 
 
The diminished SERCA 2a activity we found in TKO-mice was due to an increased 
PLB expression and a decreased PLB-Ser16 and PLB-Thr17 phosphorylation. It 
should be pointed out, that PLB-Thr17 phosphorylation was decreased, yet not totally 
absent in β1/2/3-deficient mice. For some time it has been discussed whether 
Ca
2+/calmodulin-dependent protein kinase II (CaMKII)-dependent phosphorylation of 
PLB-Thr17 is reliant on the presence of β-adrenergic stimulation or not. Whereas 
some studies came to the conclusion that phosphorylation of PLB-Ser16 and β-
adrenergic stimulation respectively are prerequisites for PLB-Thr17 phosphorylation, 
other studies reported PLB-Ser16 independent phosphorylation of PLB-Thr17. 
[reviewed in (Mattiazzi et al. 2005)] Finally experiments with a phosphatase inhibitor 
(‘okadaic acid’) showed, that PLB-Thr17 can indeed be phosphorylated in the 
absence of significantly elevated cAMP-levels or concomitant PLB-Ser16 
phosphorylation (Mundina-Weilenmann et al. 1996). Regarding the β-adrenoceptor 
independent phosphorylation of phospholamban, the important role of type 1 
phosphatase (PP1) has to be mentioned. PP1 represents the main SR phosphatase 
which among others dephosphorylates CaMKII. This facilitates CaMKII to perpetuate 
its activity independently of the intracellular Ca
2+-concentration (Bradshaw et al. 
2003). It may be speculated that this possibility of compensation eluding the β-
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adrenergic system may be responsible for the slightly sustained PLB-Thr17 
phosphorylation in TKO-mice. Further studies have to verify that assumption. 
 
It is somewhat surprising that a complex organism, that a mouse represents, can 
survive without any β-adrenoceptors. Obviously the organism has other mechanisms 
besides the β-adrenergic system with which cardiovascular function can be 
sustained. One of these mechansims might be the increased myofibrillar calcium-
sensitivity which could be found in TKO-mice. Furthermore, studies with β1-KO-mice 
could show, that heart rate in these animals is regulated by the vagal tone, therefore 
by the parasympathetic nervous system (Rohrer et al. 1998). In addition, it has been 
shown that TKO-mice have a reduced metabolic rate compared to WT (Bachman et 
al. 2002). This can be seen as a contributing factor to the reduced cardiac output 
found in these animals. So despite of a complete KO of the β-adrenoceptors the 
TKO-mice still performed even better in the running wheel tests than their WT 
littermates. Whereas both β1- and β1/2-KO-mice showed no differences in exercise 
capacity in treadmill experiments (Rohrer et al. 1999, Rohrer et al. 1998), β2-KO-mice 
also presented with an increased exercise capacity (Chruscinski et al. 1999). In these 
mice during exercise fat burning was increased which led to a prolonged availability 
of glycogene reserves in the musculature while the body fat content was significantly 
lower in β2-KO-mice compared to WT-mice. So it seems that the greater exercise 
capacity of TKO-mice may be, at least partly, attributed to the lack of the β2-AR. A 
limitation of the present study is that animals were running voluntarily. Therefore, it is 
possible that the presented data do not necessarily represent maximal exercise 
capacity of these animals. 
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CONCLUSION 
Despite  β-adrenoceptor deficiency is going along with cardiac hypotrophy and a 
decrease in cardiac function, willingness to run is not impaired. These results indicate 
that compensatory mechanisms may be activated to maintan cardiac function in 
increased cardiac stress situations. These mechanisms have to be focussed in future 
studies. 
 
ACKNOWLEDGEMENTS 
The authors would like to thank Mrs. Katja Rösler, Esra Köroglu and Kerstin Schenk 
for their excellent technical assistance. This publication contains data of the doctoral 
thesis of S.L. 
 
Disclosures 
No potential confilct of interest relevant to this article was reported. 
  16 
REFERENCES 
BACHMAN ES, DHILLON H, ZHANG CY, CINTI S, BIANCO AC, KOBILKA BK, 
LOWELL BB: betaAR signaling required for diet-induced thermogenesis and obesity 
resistance.[see comment]. Science 297: 843-5, 2002. 
BACHMAN ES, HAMPTON TG, DHILLON H, AMENDE I, WANG J, MORGAN JP, 
HOLLENBERG AN: The metabolic and cardiovascular effects of hyperthyroidism are 
largely independent of beta-adrenergic stimulation. Endocrinology  145: 2767-74, 
2004. 
BERNSTEIN D: Exercise assessment of transgenic models of human cardiovascular 
disease. Physiol Genomics 13: 217-26, 2003. 
BERS DM: Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002. 
BRADFORD MM: A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 
248-54, 1976. 
BRADSHAW JM, KUBOTA Y, MEYER T, SCHULMAN H: An ultrasensitive 
Ca2+/calmodulin-dependent protein kinase II-protein phosphatase 1 switch facilitates 
specificity in postsynaptic calcium signaling. Proc Natl Acad Sci U S A 100: 10512-7, 
2003. 
BRIXIUS K, BLOCH W, POTT C, NAPP A, KRAHWINKEL A, ZISKOVEN C, 
KORILLER M, MEHLHORN U, HESCHELER J, FLEISCHMANN B, SCHWINGER 
RH: Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and 
left ventricular human myocardium. Br J Pharmacol 143: 1014-22, 2004. 
BRIXIUS K, SAVVIDOU-ZAROTI P, MEHLHORN U, BLOCH W, KRANIAS EG, 
SCHWINGER RH: Increased Ca2+-sensitivity of myofibrillar tension in heart failure 
and its functional implication. Basic Res Cardiol 97 Suppl 1: I111-7, 2002. 
  17 
BRIXIUS K, SCHWINGER RH: Modulation of cross-bridge interaction by 2,3-
butanedione monoxime in human ventricular myocardium. Naunyn Schmiedebergs 
Arch Pharmacol 361: 440-4, 2000. 
CHRUSCINSKI AJ, ROHRER DK, SCHAUBLE E, DESAI KH, BERNSTEIN D, 
KOBILKA BK: Targeted disruption of the beta2 adrenergic receptor gene. J Biol 
Chem 274: 16694-700, 1999. 
CHU A, DIXON MC, SAITO A, SEILER S, FLEISCHER S: Isolation of sarcoplasmic 
reticulum fractions referable to longitudinal tubules and junctional terminal cisternae 
from rabbit skeletal muscle. Methods Enzymol 157: 36-46, 1988. 
DASH R, FRANK KF, CARR AN, MORAVEC CS, KRANIAS EG: Gender influences 
on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell 
Cardiol 33: 1345-53, 2001. 
DU XJ, GAO XM, WANG B, JENNINGS GL, WOODCOCK EA, DART AM: Age-
dependent cardiomyopathy and heart failure phenotype in mice overexpressing 
beta(2)-adrenergic receptors in the heart. Cardiovasc Res 48: 448-54, 2000. 
ENGELHARDT S, HEIN L, WIESMANN F, LOHSE MJ: Progressive hypertrophy and 
heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A 
96: 7059-64, 1999. 
FABIATO A, FABIATO F: Calculator programs for computing the composition of the 
solutions containing multiple metals and ligands used for experiments in skinned 
muscle cells. J Physiol (Paris) 75: 463-505, 1979. 
FRANK KF, BOLCK B, ERDMANN E, SCHWINGER RH: Sarcoplasmic reticulum 
Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57: 20-
7, 2003. 
  18 
GAUTHIER C, LEBLAIS V, KOBZIK L, TROCHU JN, KHANDOUDI N, BRIL A, 
BALLIGAND JL, LE MAREC H: The negative inotropic effect of beta3-adrenoceptor 
stimulation is mediated by activation of a nitric oxide synthase pathway in human 
ventricle. J Clin Invest 102: 1377-84, 1998. 
GAUTHIER C, TAVERNIER G, CHARPENTIER F, LANGIN D, LE MAREC H: 
Functional beta3-adrenoceptor in the human heart.[see comment]. J Clin Invest 98: 
556-62, 1996. 
GHANEM A, ROLL W, HASHEMI T, DEWALD O, DJOUFACK PC, FINK KB, 
SCHRICKEL J, LEWALTER T, LUDERITZ B, TIEMANN K: Echocardiographic 
assessment of left ventricular mass in neonatal and adult mice: accuracy of different 
echocardiographic methods. Echocardiography 23: 900-7, 2006. 
GUTH K, WOJCIECHOWSKI R: Perfusion cuvette for the simultaneous 
measurement of mechanical, optical and energetic parameters of skinned muscle 
fibres. Pflugers Arch 407: 552-7, 1986. 
JIMENEZ M, LEGER B, CANOLA K, LEHR L, ARBOIT P, SEYDOUX J, RUSSELL 
AP, GIACOBINO JP, MUZZIN P, PREITNER F: Beta(1)/beta(2)/beta(3)-adrenoceptor 
knockout mice are obese and cold-sensitive but have normal lipolytic responses to 
fasting. FEBS Lett 530: 37-40, 2002. 
KIRIAZIS H, WANG K, XU Q, GAO XM, MING Z, SU Y, MOORE XL, LAMBERT G, 
GIBBS ME, DART AM, DU XJ: Knockout of beta(1)- and beta(2)-adrenoceptors 
attenuates pressure overload-induced cardiac hypertrophy and fibrosis. Br J 
Pharmacol 153: 684-92, 2008. 
KOHOUT TA, TAKAOKA H, MCDONALD PH, PERRY SJ, MAO L, LEFKOWITZ RJ, 
ROCKMAN HA: Augmentation of cardiac contractility mediated by the human 
  19 
beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. 
Circulation 104: 2485-91, 2001. 
KRANIAS EG, SOLARO RJ: Phosphorylation of troponin I and phospholamban 
during catecholamine stimulation of rabbit heart. Nature 298: 182-4, 1982. 
LEE S, SCHWINGER RH, BRIXIUS K: Genetically changed mice with chronic 
deficiency or overexpression of the beta-adrenoceptors--what can we learn for the 
therapy of heart failure? Pflugers Arch 455: 767-74, 2008. 
MACLELLAN WR, SCHNEIDER MD: Genetic dissection of cardiac growth control 
pathways. Annu Rev Physiol 62: 289-319, 2000. 
MACLENNAN DH, KRANIAS EG: Phospholamban: a crucial regulator of cardiac 
contractility. Nat Rev Mol Cell Biol 4: 566-77, 2003. 
MATTIAZZI A, MUNDINA-WEILENMANN C, GUOXIANG C, VITTONE L, KRANIAS 
E: Role of phospholamban phosphorylation on Thr17 in cardiac physiological and 
pathological conditions. Cardiovasc Res 68: 366-75, 2005. 
MEISSNER G, HENDERSON JS: Rapid calcium release from cardiac sarcoplasmic 
reticulum vesicles is dependent on Ca2+ and is modulated by Mg2+, adenine 
nucleotide, and calmodulin. J Biol Chem 262: 3065-73, 1987. 
MONIOTTE S, KOBZIK L, FERON O, TROCHU JN, GAUTHIER C, BALLIGAND JL: 
Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic 
amines in human failing myocardium. Circulation 103: 1649-55, 2001. 
MUNCH G, BOLCK B, HOISCHEN S, BRIXIUS K, BLOCH W, REUTER H, 
SCHWINGER RH: Unchanged protein expression of sarcoplasmic reticulum Ca2+-
ATPase, phospholamban, and calsequestrin in terminally failing human myocardium. 
J Mol Med 76: 434-41, 1998. 
  20 
MUNDINA-WEILENMANN C, VITTONE L, ORTALE M, DE CINGOLANI GC, 
MATTIAZZI A: Immunodetection of phosphorylation sites gives new insights into the 
mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol 
Chem 271: 33561-7, 1996. 
ROHRER DK, CHRUSCINSKI A, SCHAUBLE EH, BERNSTEIN D, KOBILKA BK: 
Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-
adrenergic receptors. J Biol Chem 274: 16701-8, 1999. 
ROHRER DK, DESAI KH, JASPER JR, STEVENS ME, REGULA DP, JR., BARSH 
GS, BERNSTEIN D, KOBILKA BK: Targeted disruption of the mouse beta1-
adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad 
Sci U S A 93: 7375-80, 1996. 
ROHRER DK, SCHAUBLE EH, DESAI KH, KOBILKA BK, BERNSTEIN D: 
Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout 
mouse. Am J Physiol 274: H1184-93, 1998. 
SCHWINGER RH, BOHM M, SCHMIDT U, KARCZEWSKI P, BAVENDIEK U, 
FLESCH M, KRAUSE EG, ERDMANN E: Unchanged protein levels of SERCA II and 
phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac 
sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients 
with nonfailing hearts. Circulation 92: 3220-8, 1995. 
SITSAPESAN R, WILLIAMS AJ: Mechanisms of caffeine activation of single calcium-
release channels of sheep cardiac sarcoplasmic reticulum. J Physiol (Lond)  423: 
425-39, 1990. 
TIEMANN K, WEYER D, DJOUFACK PC, GHANEM A, LEWALTER T, DREINER U, 
MEYER R, GROHE C, FINK KB: Increasing myocardial contraction and blood 
  21 
pressure in C57BL/6 mice during early postnatal development. Am J Physiol Heart 
Circ Physiol 284: H464-74, 2003. 
VAN DER VELDEN J, PAPP Z, ZAREMBA R, BOONTJE NM, DE JONG JW, OWEN 
VJ, BURTON PB, GOLDMANN P, JAQUET K, STIENEN GJ: Increased Ca2+-
sensitivity of the contractile apparatus in end-stage human heart failure results from 
altered phosphorylation of contractile proteins.[comment]. Cardiovasc Res 57: 37-47, 
2003. 
VARGHESE P, HARRISON RW, LOFTHOUSE RA, GEORGAKOPOULOS D, 
BERKOWITZ DE, HARE JM: beta(3)-adrenoceptor deficiency blocks nitric oxide-
dependent inhibition of myocardial contractility. J Clin Invest 106: 697-703, 2000. 
WALLUKAT G: The beta-adrenergic receptors. Herz 27: 683-90, 2002. 
YANO M, IKEDA Y, MATSUZAKI M: Altered intracellular Ca2+ handling in heart 
failure. J Clin Invest 115: 556-64, 2005. 
 
 
  22 
TABLE 
 
Table 1: Morphometric analysis and echocardiography 
Parameter WT  TKO  p-value 
Body weight [g]  30.81 ± 3.08 (n=5)  31.00 ± 0.94 g (n=5)  0.900 
Heart weight [mg]  121 ± 3 (n=5)  94 ± 7 (n=5)  < 0.001 
Heart to body weight ratio [mg/g]  3.96 ± 0.49 (n=5)  3.02 ± 0.18 (n=5)  0.004 
Cross sectional area [% of WT]  100 ± 26.3 (n=4)  67.0 ± 31.6 (n=5)  < 0.001 
Heart rate [beats/min]  403 ± 24 (n=4)  267 ± 69 (n=7)  0.005 
Left ventricular end-systolic volume [µl]  7.4 ± 4.9 (n=4)  15.1 ± 5.0 (n=7)  0.036 
Left ventricular end-diastolic volume [µl]  37.2 ± 6.1 (n=4)  39.0 ± 6.2 (n=7)  0.649 
Ejection fraction  81 ± 11 (n=4)  62 ± 9 (n=7)  0.013 
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FIGURE LEGENDS 
 
Figure 1: The protein expression of NCX, ryanodine receptor and SERCA 2a was 
not significantly changed, whereas PLB (∗ : p < 0.02 vs. WT) expression was 
significantly increased and PLB-Ser16 (∗ : p < 0.0001 vs. WT) and PLB-Ser17 (∗ : p 
< 0.005 vs. WT) expression was decreased in TKO-mice. Data was normalized to 
Calsequestrin expression. 
 
Figure 2: The maximal activity (Vmax) of SERCA 2a in TKO-mice was 28.1 ± 16.3 
nmol ATP/mg protein/min
-1 (n = 6) compared to 144.4 ± 84.0 nmol ATP/mg 
protein/min
-1 (n = 4) in WT-mice. Thus the activity of SERCA 2a was significantly 
decreased. (∗ : p < 0.01 vs. WT) 
 
Figure 3: Whereas the maximal force (DTmax) of skinned fibers in TKO mice was 
similar to WT mice, calcium-sensitivity was significantly increased in TKO mice 
compared to WT mice. 
 
Figure 4: In running wheel tests there could not be shown any diminished exercise 
capacity of TKO mice compared to the WT. Rather an increased willingness to run 
could be observed which reached statistical significance for mean velocity (∗ : p < 
0.04 vs. WT), trip distance (∗ : p < 0.03 vs. WT) and trip time. (∗ : p < 0.04 vs. WT) 
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